Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations

Nonsense mutations promote premature translational termination and represent the underlying cause of a large number of human genetic diseases. The aminoglycoside antibiotic gentamicin has the ability to allow the mammalian ribosome to read past a false-stop signal and generate full-length functional...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nudelman, Igor, Rebibo-Sabbah, Annie, Cherniavsky, Marina, Belakhov, Valery, Hainrichson, Mariana, Chen, Fuquan, Schacht, Jochen, Pilch, Daniel S., Ben-Yosef, Tamar, Baasov, Timor
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2832307/
https://ncbi.nlm.nih.gov/pubmed/19309154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm801640k
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares